30+ Years
Self-relied Itellectual Property
30+ In Vaccine Research
400+ Research Staff
5 Production Base
International Cooperation
Development History
Production base
In vaccine research
Research staff
Available vaccine varieties
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
BioKangtai’s Shenzhen Guangming Base has passed the GMP certification in the Philippines
BioKangtai passed the EU QP audit quality management system and reached the EU GMP standard
BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell) is Approved Homologous Booster Vaccination in China
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia